Vitamin C Pricing In Supreme Court, Vitamin D QHC Petition Fails: Health And Wellness Industry News
This article was originally published in The Rose Sheet
Executive Summary
Supreme Court will hear an appeal of a circuit court's reversal of a ruling that two vitamin C importers violated US antitrust laws by conspiring to fix prices; Bayer request for vitamin D QHC for multiple sclerosis rejected; Inno-Vita warned on cleansing drug claims; and 'Prevention' clear in ABC-AHP-NCNPR program name.
You may also be interested in...
Supreme Court Vitamin C Price-Fixing Decision Could Juice Litigation Against Foreign Businesses Broadly
US businesses in any industry could use the Supreme Court's ruling that federal courts have leeway in whether to recognize a foreign country's laws as applicable in a firm's defense against unfair business practices and similar civil complaints, say attorneys tracking class-action litigation vitamin C marketers Animal Science Products and Ranis Co. filed against multiple Chinese firms supplying the ingredient.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.